ShareholderTotal shares% ownedCountry
Ronja Capital Investment AS              3 087 999 11,57 %NOR
Capra Invest AS              1 544 450 5,79 %NOR
MRFK Holding AS              1 313 960 4,92 %NOR
J.P. Morgan SE              1 101 448 4,13 %LUX
Vartdal Holding AS              1 040 286 3,90 %NOR
Brødrene Vartdal AS                  803 601 3,01 %NOR
Kotler Equity Investment Limited                  667 330 2,50 %CHN
Altitude Capital AS                  605 539 2,27 %NOR
Hawk Infinity AS                  605 201 2,27 %NOR
Stette Invest AS                  602 375 2,26 %NOR
Life Capitol AS                  591 531 2,22 %NOR
Kjølås Stansekniver AS                  574 859 2,15 %NOR
Ajea Invest AS                  555 359 2,08 %NOR
Eros AS                  520 240 1,95 %NOR
Strand Fiskeriselskap AS                  473 342 1,77 %NOR
Gold Coast Nutrition                  460 000 1,72 %NOR
Nordnet Livsforsikring AS                  352 661 1,32 %NOR
Triplenine Vedde AS                  340 000 1,27 %NOR
Melesio Invest AS                  315 000 1,18 %NOR
EM-KA AS                  292 771 1,10 %NOR
Other           10 841 388 40,62 %
Sum           26 689 340 100,00 %
Updated 31.3.2025

Nominee registered shares

In accordance with current regulations Arctic Bioscience must at least once a year make available to the public an overview of who owns nominee-registered shares in the Company, which country the shareholder is resident in and how many shares each individual owns.

The latest report has been finalized as of 14. April 2025, based on registered shares as of 21. March 2025. This report can be received by sending a request to the Company’s IR Contact.